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CONTRIBUTION 
 
What are the novel findings of this work? 
This is the first prospective study of comprehensive echocardiographic assessment including 
left and right ventricular geometry and function in women with gestational diabetes. We 
demonstrate that even a short duration of exposure to hyperglycaemia leads to 
echocardiographic changes comparable to those seen in non-pregnant diabetes mellitus. 
 
What are the clinical implications of this work? 
The echocardiographic findings in gestational diabetes may explain the increased maternal 
risk to hypertensive disorders of pregnancy and cardiovascular disease later in life.   
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ABSTRACT 
 
Objectives: To determine whether maternal cardiac adaptation at term differs in women with 
and without gestational diabetes (GDM). 
Methods: This was a prospective case-control study of pregnant women at term with and 
without GDM. Conventional as well as speckle tracking echocardiography was used to assess 
both left and right heart geometry and function. 
Results: We enrolled a total of 40 women with GDM and 40 healthy controls. Heart rate (75±9 
vs 83±10; p<0.001), left ventricular (LV) relative wall thickness (0.37±0.08 vs 0.43±0.07; 
p<0.001), LV E (early diastolic trans-mitral valve velocity) (0.73±0.12 vs 0.80±0.15; p=0.26) and 
LV A (late diastolic trans-mitral valve velocity) (0.57±0.11m/s vs 0.65±0.13m/s; p=0.006) were 
significantly raised in  GDM compared to controls. Speckle tracking analysis revealed a 
significant reduction in LV global longitudinal strain (-17.61±1.89 vs -16.29±2.26; p=0.012), LV 
endocardial global longitudinal strain (-19.84±2.35 vs -18.5±2.59; p=0.031) and LV epicardial 
longitudinal global strain (-15.73±1.66 vs -14.40±2.01; p=0.005) in GDM. Right ventricular (RV) 
analysis revealed reduced pulmonary acceleration time (66±11ms vs 58±10ms; p=0.001) , RV 
E/A  ratio (1.29±0.35 vs 1.13±0.18; p=0.017), RV A (0.39±0.08m/s vs 0.46±0.1m/s; p=0.001) as 
well as higher RV S' (myocardial systolic annular velocity) (0.14±0.02 vs 0.16±0.04; p=0.023) 
in GDM. 
Conclusion: Even a short period of exposure to hyperglycaemia as occurs in GDM, is 
associated with significant maternal functional cardiac impairment at term. Given the 
established increased post-partum cardiovascular risk after GDM, consideration should be 
given to further study of the extent of postnatal maternal cardiovascular recovery after GDM 
pregnancy. 
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INTRODUCTION 
 
Gestational diabetes (GDM) is hyperglycaemia with onset or diagnosis in pregnancy and 
occurs in one out of seven pregnancies.1,2 GDM is associated with adverse perinatal outcomes 
for both the mother and the fetus.2, 3 Women whose pregnancies were complicated with GDM 
have a more than seven-fold higher incidence of type 2 diabetes later in life.4 A recent meta-
analysis of nine studies pooling data from more than 5 million women, demonstrated that 
women who had GDM also have a two-fold higher risk of cardiovascular events in the first 
decade postpartum.5 The effect of long standing diabetes mellitus (DM) on the adult heart is 
well documented, with a wide spectrum of dysfunction including diabetic cardiomyopathy.6 
Various microvascular processes and subcellular disturbances have been shown to cause 
structural and functional damage to the diabetic heart, even without overt coronary artery 
disease.7  
 
In contrast, very little is known about the impact of short term hyperglycaemia on the heart 
as occurs in GDM. There is a lack of  prospective studies examining how GDM influences 
maternal cardiac adaptation to the increasing cardiovascular demands of pregnancy.8-13 The 
aim of the present study is to compare maternal cardiac adaptation at term in women with 
and without GDM. We hypothesized that the duration of hyperglycaemia in GDM pregnancy 
is not long enough to result in cardiovascular differences assessed using conventional 
echocardiography and speckle tracking to study left and right heart function.  
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METHODS 
 
This prospective case-control study was carried out at St. George's University Hospitals NHS 
Foundation Trust in London over a 12-month period from April 2016 until March 2017. The 
local institutional review committee approved the study (ID 12/LO/0810) and all participants 
provided written informed consent. We recruited pregnant women at term that had a 
pathological oral glucose tolerance test by 28 weeks of gestation and were classified as having 
gestational diabetes. The oral glucose tolerance test was carried out according to national 
guidelines. A fasting blood sugar was taken, and then the women received a glucose load of 
75g. After 2 hours, blood glucose was determined again. Cut off values for GDM were a fasting 
blood sugar level of ≥5.6mg/dl or a 2-hour value of ≥7.8mg/dl.3 Women who were managed 
with diet only as well as those who received oral hypoglycemic or insulin were included. Only 
women without any cardiovascular co-morbidities or any form of preexisting diabetes (type 
I, type II) were asked to take part in the study. Healthy term pregnant women with a BMI of 
30kg/m2 or less at booking and without any co-morbidity were recruited as controls. For both 
cases and controls, only women with a singleton pregnancy without pregnancy complications 
(such as preeclampsia or fetal growth restriction) were considered. Blood pressure was 
measured manually from the brachial artery according to the guidelines of the National High 
Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.14  
 
Conventional echocardiography and speckle tracking echocardiography 
Echocardiography examination and analysis were performed by a single operator (BSB) using 
a GE Vivid Q® ultrasound machine equipped with a 3.5-MHz transducer. Images were 
acquired at rest in the left lateral decubitus position from standard parasternal and apical 
views. Digital loops of 3 cardiac cycles with associated electrocardiogram information were 
stored on the hard disk of the ultrasound machine and transferred to a GE EchoPac® 
workstation for offline analysis. Analysis was performed according to existing guidelines and 
as previously described.15-17 Parasternal long-axis, short-axis and apical four chamber views 
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were used to assess left atrial volume (LAV), left ventricular volume in diastole (LVEDV), 
proximal and distal right ventricular outflow tract (RVOT) as well as other geometric indices. 
Doppler images were used to measure early and late mitral and tricuspid valve inflow 
velocities (LV and RV E and A), mitral and tricuspid inflow deceleration time (LV and RV DT), 
isovolumetric relaxation time (IVRT) and duration of the late mitral valve inflow (A dur). Left 
ventricular mass was calculated using the Devereux formula 0.8(1.04[([LVEDD + IVSd + PWd]3 
− LVEDD3)]) + 0.6v, where LVEDD is left ventricular end diastolic diameter, IVSd is thickness of 
the intraventricular septum in diastole and PWd is posterior wall thickness in diastole. Left 
ventricular mass index was calculated by deviding the left ventricular mass by the body 
surface area. Relative left ventricular wall thickness was calculated with the formula 
(2*PWd)/LVEDD. 
 
Pulsed wave tissue Doppler images were used to measure systolic (S'), early diastolic (E') and 
late diastolic (A') myocardial tissue velocities at the basal level of the septum and left and 
right ventricular walls. LV and RV longitudinal strain and systolic and diastolic (early and late) 
strain rates were calculated from apical four chamber views, with negative values indicating 
fiber shortening. LV rotation and de-rotation were calculated from apical and basal 
parasternal short axis views, with negative values indicating rotation in the clockwise 
direction. LV twist is the difference between the apical and the basal rotation, LV torsion is LV 
twist divided by left ventricular length in diastole. If >1 segment was rejected, subjects were 
excluded from statistical analysis. Diastolic dysfunction was classified according to the 
guidelines of the British Society of echocardiography applying the age and gender adapted 
values from the 2016 European Society of Cardiology Guidelines for the diagnosis and 
treatment of acute and chronic heart failure.18, 19 
 
Statistical analysis 
Descriptive statistics were performed. Continuous data were presented as mean (standard 
deviation, SD). Normal distribution was assessed using Shapiro-Wilk test. Categorical data 
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were presented as number (%) and were compared using the Chi square test. Comparisons 
between the groups were performed using either unpaired t-test or Mann Whitney U test for 
continuous data, depending on distribution of data. IBM SPSS statistics version 24 was used 
(p<0.05 considered as significant). Intra- and interobserver variablility has been performed as 
previously described by our group20 and was not repeated in this study. 
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RESULTS 
 
We enrolled a total of 80 pregnant women at term, 40 women with GDM and 40 healthy 
women. Conventional echocardiography evaluation of the left ventricle could be performed 
in all women, but speckle-tracking analysis could not be performed in four controls and seven 
GDM women. Demographic characteristics of the control and GDM groups are shown in Table 
1. GDM women had a significantly higher BMI and a higher systolic blood pressure at booking 
and at inclusion into the study compared to controls. 
 
Echocardiographic indices were not significantly different between the two groups (Table 2) 
with the exception of the heart rate, relative left ventricular wall thickness, left ventricular E 
(early diastolic trans-mitral valve velocity) and A (late diastolic trans-mitral valve velocity), 
which were significantly raised in  GDM. Of special note is that left ventricular mass and left 
ventricular mass index did not differ significantly between groups. Longitudinal strain analysis 
of the left ventricle showed significant reduction in global strain, endocardial global strain and 
epicardial global strain in GDM pregnancies (Figure1). Right ventricular analysis revealed 
reduced pulmonary acceleration time and RV E/A ratio as well as higher RV S' (myocardial 
systolic annular velocity) and RV A in the GDM population. Speckle tracking analysis of the 
right ventricle did not reveal any differences between the control and the GDM group 
(Supplementary Table A). 
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DISCUSSION 
 
Women with GDM at term had a significantly impaired cardiac function compared to healthy 
control pregnancies as demonstrated by significantly increased left ventricular relative wall 
thickness and reduced longitudinal left ventricular global strain, longitudinal left ventricular 
endocardial and longitudinal epicardial global strain. These subclinical changes suggest a 
significantly maladaptive cardiovascular response in apparently uncomplicated term GDM 
pregnancy. 
 
Outside pregnancy, Enomoto et al. studied systolic dysfunction with speckle tracking in 
normotensive diabetic patients and found a reduction in global longitudinal and 
subendocardial strain.21 However, the effect of diabetes on the heart is confounded by the 
common co-existence of metabolic syndrome, where the effect on cardiac function is 
influenced not only by diabetes, but also hypertension and dyslipidaemia. Studies assessing 
cardiac changes in metabolic syndrome also found decreased longitudinal and circumferential 
strain in the left ventricle22, 23 and decreased global longitudinal strain in the right ventricle.24 
It is notable that exposure of the maternal heart to a short period of hyperglycaemia parallels 
the cardiac dysfunction seen in non-pregnant patients after decades of diabetes. There is one 
previous retrospective study of 18 pregnant women with GDM at the end of the second 
trimester. The authors demonstrated differences only in global longitudinal strain with 
preserved circumferential and radial strain in GDM.25 Although this data supports the findings 
of the present study, the lack of additional cardiovascular findings may be explained by the 
retrospective nature of the study, smaller sample size, reduced loading conditions of earlier 
gestation of assessment and a shorter period of exposure to hyperglycaemia. Two prospective 
conventional echocardiographic studies found an increase in left ventriuclar wall thickness 
and decreased diastolic function supporting our findings.11, 12   
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GDM is a strong risk factor for the development of hypertensive disorders of pregnancy and 
fetal growth26, 27 – both pathologies where recent work has shown significant deficits in 
maternal cardiovascular function28, 29. By deliberately excluding GDM pregnancies that 
developed these complications from our study, we may have inadvertently introduced 
exclusion bias by not studying women who developed cardiac dysfunction as a consequence 
of these pregnancy complications. Hence, our data is more reflective of the cardiac function 
in apparently ‘healthy’ GDM pregnancy rather than showing the evolution of more severe 
cardiac dysfunction as has been shown to occur with the development of preeclampsia or 
fetal growth restriction28, 29. Despite these exclusions, it is notable that the prevalence of 
diastolic dysfunction is 2.8-fold higher in GDM compared to normal pregnancy at term. The 
latter observation has previously been implicated in the development of hypertensive 
disorders of pregnancy. 
 
The mechanism by which diabetes causes cardiac dysfunction outside pregnancy are not 
entirely understood and the spectrum of diabetic cardiovascular effects including myocardial 
fibrosis, remodeling, diastolic dysfunction and later systolic dysfunction are commonly 
described as diabetic cardiomyopathy. Impaired cardiac insulin signaling, mitochondrial 
dysfunction, oxidative stress, advanced glycation, cardiomyocyte calcium handling, 
inflammation, renin–angiotensin–aldosterone system activation and microvascular 
dysfunction have all been implicated in the development and progression of diabetic 
cardiomyopathy, myocardial damage and subsequent fibrosis30, 31. A recent meta-analysis 
found that women who had GDM during pregnancy have a two-fold higher risk of 
cardiovascular events in the first decade postpartum, independent of whether or not they 
develop postpartum type II diabetes.5 The authors postulated that GDM, like preeclampsia, 
may unmask during pregnancy those women who have a higher postpartum cardiovascular 
risk29, 32, 33. It would be interesting to postulate that the pathophysiology of cardiovascular 
dysfunction in GDM pregnancy may lead to long-term myocardial damage and fibrosis as is 
known to occur in diabetic cardiomyopathy. Future studies should evaluate postpartum 
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cardiovascular function after GDM pregnancy and determine whether persistent myocardial 
dysfunction is caused by GDM pregnancy alone or is confounded by the effects of other 
cardiovascular risk factors. 
 
Strength and limitations 
The strengths of our study are that it is prospective in design and assessed both left and right 
heart function using conventional as well as speckle tracking echocardiography to evaluate 
cardiac function. The weakness of our study is that women who developed GDM also had a 
higher booking BMI and systolic blood pressure. It is not possible to delineate to what extent 
the former factors may have influenced the development of the cardiovascular dysfunction 
noted in GDM pregnancy. Reassuringly, our previous work demonstrated maternal 
cardiovascular dysfunction in non-diabetic pregnancy with BMI>35kg/m2, which is 
substantially higher than the BMI of our GDM population. Pregnant women with a 
BMI>35kg/m2 had a significantly higher SV, CO and LVM and a significantly lower TVR. If 
corrected for maternal weight, the differences disappeared except for LVMI. The GDM group 
showed no difference in SV, SVI, CO, CI, LVM, LVMI, TVR and TVRI compared to controls. We 
therefore feel confident to relate the observed differences in speckle tracking and in diastolic 
dysfunction to the presence of GDM and not to the higher BMI in the GDM group. 
Interestingly, diastolic dysfunction, if present, was more severe in GDM pregnancy than in the 
obese pregnancy. Furthermore, women in the GDM group were, on average, scanned two 
weeks earlier than the control group. As maternal cardiac maladaptation increases with 
advancing gestation, the latter difference would have only served to ameliorate, rather than 
exaggerate, any differences between GDM and normal pregnancy.8 
 
Conclusion 
A short period of exposure to hyperglycaemia as occurs in GDM, is associated with significant 
maternal functional cardiac impairment at term. Given the established increased post-partum 
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cardiovascular risk after GDM, consideration should be given to further study of the extent of 
postnatal maternal cardiac recovery after GDM pregnancy. 
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FIGURE LEGEND 
 
Figure 1: Representative speckle tracking and strain rate analysis in GDM (A, B, C) and 
control (D, E, F). GSendo = global endocardial strain; GS = global strain; GSepi = global 
epicardial strain. 
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Table 1: Demographic characteristics of women with normal and GDM pregnancy 
 Controls (n=40) GDM (n=40) p-value 
Maternal age (years) 34.8 (4.0) 33.2 (4.5) 0.099 
Ethnicity: 
- Caucasian 
- Afro-Caribbean 
- Asian 
 
34 (85.0%) 
2 (5.0%) 
4 (10.0%) 
 
25 (62.5%) 
4 (10.0%) 
11 (27.5%) 
0.001 
Parity: 
- Nulliparous 
- Multiparous 
 
16 (40.0%) 
24 (60.0%) 
 
20 (50.0%) 
20 (50.0%) 
<0.001 
Booking visit BMI (kg/m2) 23.7 (2.5) 30.4 (8.0) <0.001 
Booking visit SBP (mmHg) 109 (11) 119 (13) <0.001 
Booking visit DBP (mmHg) 67 (8) 72 (9) 0.012 
Gestation at assessment (weeks) 39.3 (1.0) 37.0 (1.3) <0.001 
BMI at assessment (kg/m2) 28.1 (3.0) 32.6 (6.9) <0.001 
SBP at assessment (mmHg) 109 (9) 114 (11) 0.024 
DBP at assessment (mmHg) 74 (8) 74 (9) 0.790 
Results are shown as mean (±SD) or number of subjects (percentage). GDM=gestational diabetes; 
BMI=body mass index; SBP=systolic blood pressure; DBP=diastolic blood pressure 
 
  
This article is protected by copyright. All rights reserved.
  
 
Table 2: Left ventricular hemodynamic, geometric and speckle tracking-derived indices 
 Controls (n=40) GDM (n=40) p-value 
Hemodynamic Indices 
HR (min-1) 75 (9) 83 (10) <0.001 
SV (ml) 66 (11) 64 (13) 0.346 
SVI (ml*m-2) 36 (6) 34 (7) 0.143 
CO (ml*min-1) 4896 (849) 5295 (1239) 0.163 
CI (ml*min*m-2) 2664 (439) 2797 (537) 0.227 
TVR (dynes*s-1*cm-5) 1448 (332) 1390 (347) 0.448 
TVRI (dynes*s-1*cm-5*m-2) 2658 (605) 2605(634) 0.704 
Average S' (m/s) 0.10 (0.02) 0.10 (0.02) 0.746 
Geometric Indices 
LAV (ml) 55 (12) 57 (14) 0.507 
LAVI (ml*m-2) 30 (6) 30 (7) 0.877 
LVM (g) 119 (21) 128 (36) 0.172 
LVMI (g*m-2) 64 (10) 67 (13) 0.365 
RWT 0.37 (0.08) 0.43 (0.07) <0.001 
Mitral inflow indices 
E (m/s) 0.73 (0.12) 0.80 (0.15) 0.026 
A (m/s) 0.57 (0.11) 0.65 (0.13) 0.006 
E/A ratio 1.28 (0.18) 1.26 (0.30) 0.699 
Septal E' (m/s) 0.10 (0.03) 0.10 (0.02) 0.567 
Lateral E' (m/s) 0.15 (0.04) 0.15 (0.03) 0.843 
E/E' average 6.18 (1.57) 7.02 (2.82) 0.103 
Diastolic function 
Normal 
Grade 1 Diastolic Dysfunction 
35 (87.5) 
4 (10) 
26 (65) 
2 (5) 
0.010 
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Grade 2 Diastolic Dysfunction 
Grade 3 Diastolic Dysfunction 
1 (2.5) 
0 (0) 
12 (30) 
0 (0) 
 
Strain and strain rate indices 
LV global strain (%) -17.61 (1.89) -16.29 (2.26) 0.012 
LV endocardial global strain (%) -19.84 (2.35) -18.50 (2.59) 0.031 
LV epicardial global strain (%) -15.73 (1.66) -14.40 (2.01) 0.005 
LV longitudinal strain rate (s-1) -0.98 (0.12) -0.96 (0.15) 0.509 
LV early diastolic strain rate (s-1) 1.24 (0.26) 1.15 (0.32) 0.235 
LV late diastolic strain rate (s-1) 0.55 (0.16) 0.60 (0.19) 0.302 
Twist and torsion indices 
LV twist (degree) 14.33 (5.69) 16.39 (6.69) 0.223 
LV torsion (degree*cm-1) 1.66 (0.66) 1.88 (0.76) 0.252 
LV twist rate (degree*s-1) 102 (48) 134 (55) 0.048 
LV un-twist rate (degree*s-1) -106 (56) -125 (47) 0.194 
Results are shown as mean (±SD). HR=heart rate; SV=stroke volume; SVI=stroke volume index; 
CO=cardiac output; CI=cardiac index; TVR=total vascular resistance; TVRI=total vascular resistance index; 
Average S'=systolic tissue Doppler average velocity at the septal/lateral mitral valve annulus; LAV=left 
atrial volume; LAVI=left atrial volume index; LVM=left ventricular mass; LVMI=left ventricular mass 
index; RWT=relative left ventricular wall thickness; E=peak early diastolic transmitral valve velocity; 
A=peak late diastolic transmitral valve velocity; Septal/lateral E'=peak early diastolic tissue Doppler 
velocity at the septal/lateral mitral valve annulus; E/E' average=E to average lateral and septal E' ratio 
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